Calmodulin Binding Domains in Critical Risk Proteins Involved in Neurodegeneration
Open Access
- 21 November 2022
- journal article
- research article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 44 (11) , 5802-5814
Abstract
Neurodegeneration leads to multiple early changes in cognitive, emotional, and social behaviours and ultimately progresses to dementia. The dysregulation of calcium is one of the earliest potentially initiating events in the development of neurodegenerative diseases. A primary neuronal target of calcium is the small sensor and effector protein calmodulin that, in response to calcium levels, binds to and regulates hundreds of calmodulin binding proteins. The intimate and entangled relationship between calmodulin binding proteins and all phases of Alzheimer’s disease has been established, but the relationship to other neurodegenerative diseases is just beginning to be evaluated. Risk factors and hallmark proteins from Parkinson’s disease (PD; SNCA, Parkin, PINK1, LRRK2, PARK7), Huntington’s disease (HD; Htt, TGM1, TGM2), Lewy Body disease (LBD; TMEM175, GBA), and amyotrophic lateral sclerosis/frontotemporal disease (ALS/FTD; VCP, FUS, TDP-43, TBK1, C90rf72, SQSTM1, CHCHD10, SOD1) were scanned for the presence of calmodulin binding domains and, within them, appropriate binding motifs. Binding domains and motifs were identified in multiple risk proteins, some of which are involved in multiple neurodegenerative diseases. The potential calmodulin binding profiles for risk proteins involved in HD, PD, LBD, and ALS/FTD coupled with other studies on proven binding proteins supports the central and potentially critical role for calmodulin in neurodegenerative events.Keywords
This publication has 66 references indexed in Scilit:
- Multiple instance learning of Calmodulin binding sitesBioinformatics, 2012
- α-Synuclein Interacts with Glucocerebrosidase Providing a Molecular Link between Parkinson and Gaucher DiseasesJournal of Biological Chemistry, 2011
- Calmodulin regulates the non-amyloidogenic metabolism of amyloid precursor protein in plateletsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Calcineurin inhibition with FK506 ameliorates dendritic spine density deficits in plaque-bearing Alzheimer model miceNeurobiology of Disease, 2011
- Neuroprotective Effects of Calmodulin Peptide 76‐121aa: Disruption of Calmodulin Binding to Mutant HuntingtinBrain Pathology, 2009
- Intracellular Calcium Deficits in Drosophila Cholinergic Neurons Expressing Wild Type or FAD-Mutant PresenilinPLOS ONE, 2009
- Transglutaminase Activation in Neurodegenerative DiseasesFuture Neurology, 2009
- Calmodulin Regulates Transglutaminase 2 Cross-Linking of HuntingtinJournal of Neuroscience, 2004
- Parkinson's Disease-associated α-Synuclein Is a Calmodulin SubstrateJournal of Biological Chemistry, 2003
- Calcium Hypothesis of Alzheimer's Disease and Brain AgingaAnnals of the New York Academy of Sciences, 1994